A Study of MK-6213 Co-Administered With Atorvastatin in Participants With Hypercholesterolemia (MK-6213-006)
Status:
Completed
Trial end date:
2009-01-08
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the safety and effectiveness of MK-6213 as compared to
MK-6213/Atorvastatin in participants 18 to 75 years) with high cholesterol.